Skip to main content
Inflo Health logo
INFLO HEALTH at RSNA 2026
Technical Exhibits | Nov 29 – Dec 2, 2026 | Chicago | McCormick Place | Booth 5528

From Actionable Finding to Completed Care

Meet Inflo Health at RSNA 2026, Booth 5528, and see how Inflo Universal turns every actionable diagnostic finding — across radiology, cardiology, and beyond — into care that is completed, confirmed, and measured.

Welcome, RSNA 2026 Attendees

Inflo Health is proud to join the radiologists, imaging leaders, quality officers, informaticists, and operators gathering in Chicago.

Visit Booth 5528 to see what happens after the finding: how high-reliability follow-up extends your team’s reach, protects patients from falling out of care, and proves closure with numbers you can take to your board.

RSNA 2026 Conference
Meet Us at Booth 5528
Calculate Your Follow-Up Revenue Gap

Where Are Your Follow-Ups Getting Stuck?

Radiology departments are absorbing rising study volume, navigator turnover, incidental findings without owners, out-of-network patients, and follow-up tracking that still lives in spreadsheets.
Inflo addresses these pressures through one universal solution. These are not separate products. They are capabilities within one governed model: Clinical Intelligence × Human Escalation — AI where it is reliable, people where it matters.

Use the Follow-Up Revenue Gap Calculator

Estimate how many actionable findings go unclosed each year in your organization, what that costs in downstream revenue, and what closing the gap would return.
Calculate Your Follow-Up Revenue Gap

How Can Radiology Departments Make Follow-Up Reliable?

A missed follow-up is usually not a human problem.
It is a capacity and organization problem.

Detection is largely solved. Across 10 million studies analyzed, roughly 15% contain a follow-up recommendation requiring action — and we identify 100% of them. The bottleneck is what happens to that list next. Handing a navigator 50 findings to sort through in order to reach the 2 that need action today is not a workflow. It is a queue.

Finding Identification

Inflo’s diagnostic-specific models read unstructured reports and identify what is genuinely actionable, working with the documentation your radiologists already produce:
  • Explicit and incidental findings across all modalities
  • Appropriateness assessment against clinical context
  • Hedged and inconclusive language separated from clear recommendations
  • No changes to dictation, pick lists, or reporting platforms
  • Compatible with lists generated by any other vendor

Workload Organization

Every finding is then categorized so human attention lands where it is needed:
  • Clear follow-ups not yet worked or closed
  • Findings requiring a second look because the recommendation lacks specificity
  • Findings missing information needed to act, such as a working phone number
  • Auto-closure candidates, with full transparency into what was automated and why
  • Escalation paths to navigators and, as a fail-safe, our call center
The objective is not simply to surface more findings. It is to make the resulting workload something a real team can finish — which is why our customers report a 95% reduction in manual follow-up tasks with no added headcount.
See Inflo Universal Follow-up at Booth 5528

Introducing Inflo Universal

One Platform for Every Finding That Requires Action

Health systems are fatigued by point solutions. A radiology-only tool solves a radiology-only problem, and the patient with an incidental finding on a cardiac study, an abnormal lab, or a pathology result that needs a repeat is served by no one.
Inflo Universal extends the platform we run in radiology to any diagnostic source where a result requires a next step. One investment, one contract, one integration, serving your entire organization.

The loop, applied to any finding:

IDENTIFY — Find every actionable finding, explicit and incidental, across specialties.
ORGANIZE — Sort findings into auto-closure, escalation, and second-look workflows.
ACTIVATE — Reach the patient and the ordering provider, inside your EHR and beyond it.
CLOSE — Confirm completion as a measured event, and report it.

What is live today:

  • Radiology — proven in production. Deployed across 14 health systems with published outcomes.
  • Cardiology — generally available. 38,000 follow-ups closed across six clinical indications in five months.
  • Lab and pathology — in active development. Targeted availability in 2027.
In a market crowded with roadmap claims, knowing exactly what is deployed and what is coming is part of what makes a follow-up program reliable.
See What’s Live at Booth 5528

How Do You Prove a Follow-Up Actually Closed?

Most systems can tell you a finding was documented. Some can tell you an order was placed.
Very few can tell you the care happened.
Closure is the hardest problem in follow-up, because real care rarely follows the recommendation exactly. The patient gets the scan two months late. At a different facility. As a different study. Or their symptoms resolved and the follow-up is genuinely no longer indicated. A system that cannot recognize those events sends navigators chasing patients who are already finished — and reports a closure rate it cannot defend.
Inflo tracks every follow-up from generation through resolution and detects closure as a measured event:
  • Completion recognized even when the action differs from the recommendation
  • Care captured when it occurs outside your health system
  • Full audit trail of notification, understanding, and action
  • Operational, clinical, and financial reporting built on confirmed closures
  • Closure rates by service line, finding type, referring provider, and cohort
The objective is to answer the one question that matters: what percentage of the care your physicians recommended actually got done?
Across our customer base, programs close 60–90% of all follow-ups, against a typical starting baseline of 40–50%.
Bring Us Your Closure Rate

How Do You Reach Patients Who Never Log In?

Most systems can tell you a finding was documented. Some can tell you an order was placed.
Very few can tell you the care happened.
Patients do not live in Epic. They do not have a PCP, they are out of network, they never activated the portal, and they received an immediate release of a report they cannot read. Then they are asked to schedule a scan they do not understand the reason for.
Inflo Engage is built for that patient.
The Front Door Outreach reaches the patient where they actually are:
  • A text message specific to their finding and their result
  • A secure link that opens the Inflo app — no portal account required
  • Timing, framing, and complexity that adapt to how each patient responds
  • Ordering and out-of-network providers engaged through trackable communication
The Translation Once inside the app, the patient gets what a report cannot give them:
  • Their result explained in plain language at a fifth-grade reading level
  • Why the follow-up matters and what happens if it is delayed
  • Definitions for the terms that frighten people
  • The next step, and scheduling options to take it
A place to say what is standing in the way — transportation, cost, language, caregiving — which becomes a workflow trigger routed to a navigator with context attached.
Every interaction adds to what patients tell us about where they disengage and what restores follow-through.
Explore Inflo Engage at RSNA
info@inflohealth.com

What Is the Follow-Up Gap Costing Your Organization?

This Follow-Up Revenue Gap Calculator estimates how many actionable findings go unclosed in your organization each year, the associated downstream revenue, and the return on closing the gap.
The calculator considers factors such as:
  • Annual diagnostic study volume
  • Share of studies containing an actionable follow-up recommendation
  • Current follow-up closure rate
  • Net revenue per downstream encounter
  • Closure improvement scenario
  • Projection period
Calculate your exposure, then bring the results to Booth 5528. Our team can help you address the next operational question: which of those findings can close automatically, which need a navigator, and how you would prove either one.
Print this Report
Discuss My Results at Booth 5528
Copy Shareable Link

Your target closure rate

%
%
%

Pick a scenario above, or set a target per program.

Your imaging volume

Program mix and % of studies with recommendation for additional imaging

%
%
%
%
—
%

This rate typically falls between 10% and 17%.

Your current closure rate

%
%
%

Blended reimbursement per recovered patient

$
$
$
Estimated incremental imaging revenue
—

—

Additional patients servedrecovered follow-ups per year —
Patients lost today— —
Blended closure rate— —

Revenue by program

ProgramRecommended follow-upsClosed todayRecovered patientsBlended rateIncremental revenue
Estimates only. Incremental revenue is the additional follow-ups closed at your target rate versus today, priced at your blended reimbursement per recovered patient. This reflects imaging revenue only; it excludes downstream procedure revenue and does not net out program cost. Figures swing heavily with your payer mix, protocol design, and program maturity, and are not a guarantee of financial performance. No patient-identifiable information is collected, transmitted, or stored by this page; all calculations run locally in your browser.

Meet Inflo Health at RSNA 2026

Bring Us Your Hardest Follow-Up Problem

Where is your program breaking down? Is it incidental findings without an owner, hedged recommendations that stall in review, patients with no PCP or no portal account, out-of-network care you cannot see, navigator turnover, a closure rate nobody can defend, or a follow-up backlog your current tool identifies but never resolves?
Meet the Inflo Health team at Booth 5528 to see how high-reliability follow-up closes the execution gap.